Vultaggio Vincent sold ZNTL
February 10, 2026 · Form 4 insider transaction
Vultaggio Vincent sold 6,894 shares of Zentalis Pharmaceuticals, Inc. at $2.42 per share, a transaction worth $16.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
6,894
Price
$2.42
Total value
$16.7K
InsiderVultaggio Vincent
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 10, 2026
Filing dateFebruary 10, 2026
Shares owned after146,506
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 18, 2025.